The Platelet in Uremia

Lewis J.H. , Zucker M.B. , and Ferguson J.H. : Bleeding tendency in uremia. Blood 11: 1073–1076, 1956.

Rath C.E. , Maillard J.A. , and Schreiner G.E. : Bleeding tendency in uremia. N. Eng. J. Med. 257: 808–811, 1957.

Cahalane S.F. , Johnson S.A. , Monto R.W. , and Caldwell M.J. : Acquired thrombocytopathy: observations on the coagulation defect in uremia. Am. J. Clin. Path. 30: 507–513, 1958.

Willoughby M.L.N. , and Crouch S.J. : An investigation of the haemorrhagic tendency in renal failure. Brit. J. Haemat 7: 315–326, 1961.

Salzman E.W. , and Neri L.L. : Adhesiveness of blood platelets in uremia. Thromb. et Diath. Haemorrh. 15: 84–92, 1966.

Horowitz H.I. , Cohen B.D. , Martinez P. , and Papayoanou M.F. : Defective ADP-induced platelet factor 3 activation in uremia. Blood 30 311–340, 1967.

Horowitz H.I. , Stein I.M. , Cohen B.D. , and White J.G. : Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am. J. Med. 49: 336–345, 1970.

Rabiner S.F. , and Hrodek O. : Platelet factor 3 in normal subjects and patients with renal failure. J. Clin. Invest. 47: 901–912, 1968.

Rabiner S.F. , and Molinas F. : The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am. J. Med. 49: 346–351, 1970.

Eknoyan G. , Wacksman S.J. , Glueck H.I. , and Will J.J. : Platelet function in renal failure. N. Eng. J. Med. 280: 677–681, 1969.

Praga C. , and Cortellaro M. : Diminuzione dell'adesivita piastrinica al vetro in soggetti normali dopo carico orale di creatinina. (cited by H. Horowitz, reference 13).

Lindsay R.M. , Moorthy A.V. , Koens F. , and Linton A.L. : Platelet function in dialyzed and non-dialyzed patients with chronic renal failure. Clin. Nephrol. 4: 52–57, 1975.

Horowitz H. : Uremic toxins and platelet function. Arch. Int. Med. 126: 823–826, 1970.

Weiss H.J. , Rogers J. , and Brand H. : Properties of the platelet retention (von Willebrand) factor and its similarity to antihemophilic factor (AHF) Blood 41: 809–815, 1973.

Kazatchkine M. , Sultan Y. , Caen J.P. , and Bariety J. : Bleeding in renal failure: a possible cause. Brit. M. J. 2: 612–615, 1976.

Ruggeri Z.M. , Ponticelli C. , and Mannucci P.M. : Factor VIII and chronic renal failure. Brit. M. J. 1: 1085, 1977.

Remuzzi G. , Livio M. , Roncaglioni M.C. , Mecca G. , Donati M.B. , and de Gaetano G. : Bleeding in renal failure: Is von Willebrand factor implicated? Brit. M. J8. 2: 359–361, 1977.

Warrell R.P. Jr. , Hultin M.B. , and Coller B.S. : Increased factor VIII / von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am. J. Med. 66: 226–228, 1979.

Lindner A. , Charra B. , Sherrard D.J. , and Scribner B.H. : Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med. 290: 697–701, 1974.

Hamberg M. , Svensson J. , and Samuelsson B. : Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Nat. Acad. Sci. U.S.A. 72: 2994–2998, 1975.

Moncada S. , Gryglewski R. , Bunting S. , and Vane J.R. : An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665, 1976.

Remuzzi G. , Cavenaghi A.E. , Mecca G. , Donati M.B. , and de Gaetano G. : Prostacyclin-like activity and bleeding in renal failure. Lancet 2: 1195–1197, 1977.

Remuzzi G. , Marchesi D. , Livio M. , Cavenaghi A.E. , Mecca G. , Donati M.B. , and de Gaetano G. : Altered platelet and vascular prostaglandin-generation in patients with renal failure and prolonged bleeding times. Thromb. Res. 13: 1007–1015, 1978.

Harter H.R. , Burch J.W. , Majerus P.W. , Stanford N. , Delmez J.A. , Anderson C.B. , and Weerts C.A. : Prevention of thrombosis in patients on hemodialysis by low dose aspirin. N. Engl. J. Med. 301: 577–579, 1979.